IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 207 filers reported holding IMMUNOGEN INC in Q1 2018. The put-call ratio across all filers is 3.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $576,000 | +85.8% | 112,765 | -11.9% | 0.03% | +75.0% |
| Q3 2019 | $310,000 | -7.7% | 127,945 | -17.4% | 0.02% | -15.8% |
| Q2 2019 | $336,000 | -72.1% | 154,902 | -65.2% | 0.02% | -73.6% |
| Q1 2019 | $1,206,000 | +161.6% | 445,118 | +813.2% | 0.07% | +242.9% |
| Q3 2018 | $461,000 | -52.6% | 48,745 | -47.3% | 0.02% | -46.2% |
| Q1 2018 | $972,000 | -23.5% | 92,456 | -44.3% | 0.04% | -40.0% |
| Q3 2017 | $1,270,000 | +392.2% | 166,036 | +97.5% | 0.06% | +400.0% |
| Q2 2016 | $258,000 | -91.8% | 84,049 | -76.2% | 0.01% | -88.1% |
| Q1 2015 | $3,157,000 | +113.6% | 352,751 | +45.5% | 0.11% | +98.2% |
| Q4 2014 | $1,478,000 | +189.2% | 242,432 | +607.5% | 0.06% | +103.7% |
| Q1 2014 | $511,000 | -67.8% | 34,268 | -63.2% | 0.03% | -68.6% |
| Q3 2013 | $1,585,000 | -42.7% | 93,173 | -44.1% | 0.09% | -5.5% |
| Q2 2013 | $2,766,000 | – | 166,744 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 10,906,962 | $69,914,000 | 3.04% |
| Fernwood Investment Management, LLC | 224,500 | $1,439,000 | 0.77% |
| Telemetry Investments, L.L.C. | 272,000 | $1,744,000 | 0.66% |
| Schonfeld Strategic Advisors LLC | 865,356 | $5,547,000 | 0.45% |
| Virtus ETF Advisers LLC | 53,977 | $346,000 | 0.43% |
| Endurant Capital Management LP | 210,800 | $1,351,000 | 0.41% |
| SPHERA FUNDS MANAGEMENT LTD. | 500,000 | $3,205,000 | 0.38% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 113,216 | $726,000 | 0.37% |
| Orbimed Advisors | 2,834,126 | $18,167,000 | 0.23% |
| PINNACLE ASSOCIATES LTD | 1,322,231 | $8,476,000 | 0.16% |